Figure 2: Activation of FRS2alpha and ERK by FGF-19 (human) (rec.) (His) (Prod. No.
ALX-201-420) in rat hepatoma cells.Method: H4IIE rat hepatoma cells were serum starved for 16h and then stimulated with recombinant hFGF-19-His or FGF-b for 10min respectively. FGF-b (100ng/ml) was used as positive control. The cell lysate was subjected to immunoblotting with antibodies against pFRS2alpha, pERK1/2, total ERK1/2.Lane 1: control (non-treated)Lane 2: hFGF-19-His 30ng/mlLane 3: hFGF-19-His 100ng/mlLane 4: hFGF-19-His 300ng/mlLane 5: hFGF-19-His 1000ng/mlLane 6: FGF-b 100ng/ul